| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Skyknight Capital, L.P. last filed a Form 4 in June 2022, as Director at AHCO.
At the last filing, the largest reported position was 100,000 shares of AHCO. Net of sales, the AHCO filings show accumulation of 100,000 shares.
Skyknight Capital, L.P. has 1 Form 4 filing on record in June 2022, as Director at AdaptHealth (AHCO), 2022.
The 2 reported transactions were 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $1.7M and no sales.
The only open-market purchase was 100,000 shares of AHCO at an average $17.07 on June 14, 2022, about $1.7M. Twelve months later AHCO was down 42%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2022 | AHCO Adapthealth Corp. | Director | Buy | 100,000 | $17.07 | $1,707,287.70 | New | +14.8% | -42.1% |